First Interstate Bank Astrazeneca PLC Transaction History

First Interstate Bank

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2020 May 11, 2020	SELL	$37.79 - $51.33 $22,674 - $30,798	-600 Closed	0 $0
Q4 2019 Feb 06, 2020	SELL	$42.46 - $50.46 $42,672 - $50,712	-1,005 Reduced 62.62%	600 $30,000
Q3 2019 Oct 30, 2019	SELL	$40.12 - $45.47 $34,904 - $39,558	-870 Reduced 35.15%	1,605 $72,000
Q2 2019 Aug 05, 2019	SELL	$37.28 - $41.68 $5,778 - $6,460	-155 Reduced 5.89%	2,475 $102,000
Q1 2019 May 02, 2019	SELL	$35.49 - $43.02 $74,174 - $89,911	-2,090 Reduced 44.28%	2,630 $106,000
Q4 2017 Feb 13, 2018	SELL	$32.09 - $34.78 $13,060 - $14,155	-407 Reduced 7.94%	4,720 $164,000
Q3 2017 Nov 08, 2017	BUY	$28.96 - $34.0 $148,477 - $174,318	5,127	5,127 $174,000

1,376

476M

6.08M

4.44M

Ticker AZN
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 3,099,020,032
Market Cap $211B
Description
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...

Get notified when there are updates to the investment portfolio of First Interstate Bank, based on Form 13F filings with the SEC.

Stay updated on First Interstate Bank with notifications on news.